MBXBF (Microbix Biosystems) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jun. 30, 2026)


MBXBF Microbix Biosystems Inc MBXBF
53 GF Score
Price $0.21
GF Value $0.17
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Float Percentage Of Total Shares Outstanding?

Microbix Biosystems MBXBF 53 Float Percentage Of Total Shares Outstanding is 0.00% as of Jun. 30, 2026. GuruFocus rates MBXBF with a GF Score™ of 53/100 and a GF Value™ of $0.17 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Microbix Biosystems's float shares is 0.00 Mil. Microbix Biosystems's total shares outstanding is 137.50 Mil. Microbix Biosystems's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Microbix Biosystems's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Microbix Biosystems's Institutional Ownership is 0.22%.

MBXBF
53GF Score
Microbix Biosystems Inc MBXBF
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Microbix Biosystems's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/137.50
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Microbix Biosystems (MBXBF) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Float Percentage Of Total Shares Outstanding too high?
Microbix Biosystems' current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Microbix Biosystems has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Microbix Biosystems' Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.17, compared to a current price of $0.21 — trading 23.5% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Microbix Biosystems' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.21 is trading 23.5% above its estimated GF Value™ of $0.17. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: $0.17 vs. price of $0.21 (23.5% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
53GF Score

Get the complete analysis for MBXBF

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price
$0.17
GF Value